{"date":"2025-04-23","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6543-2025-04-23-1855-19wml01","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-04-23","time":"18:55:41","subject":"公告本公司董事會決議通過對100％投資之子公司越南台灣普惠醫療工藝責任有限公司現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-04-23 18:55，「公告本公司董事會決議通過對100％投資之子公司越南台灣普惠醫療工藝責任有限公司現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-04-23-1842-ot0rjs","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"18:42:42","subject":"公告本公司召開重大訊息說明記者會新聞稿內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-04-23 18:42，「公告本公司召開重大訊息說明記者會新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-04-23-1841-pgs9t3","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"18:41:05","subject":"本公司經審慎評估，決定依資料及安全監測委員會對於Adagloxad Simolenin (OBI-822)三期臨床試驗第二次期中分析之建議，終止該試驗，將資源投入次世代抗體藥物複合體開發","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-04-23 18:41，「本公司經審慎評估，決定依資料及安全監測委員會對於Adagloxad Simolenin (OBI-822)三期臨床試驗第」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-04-23-1807-isqttc","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-04-23","time":"18:07:48","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-04-23 18:07，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-04-23-1806-8gn1d","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-04-23","time":"18:06:54","subject":"公告本公司一一四年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-04-23 18:06，「公告本公司一一四年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-04-23-1745-rum7fr","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"17:45:32","subject":"公告本公司今日接獲註冊代理人通知，埃及藥物監督管理局(EDA)受理Bonvadis外用乳膏完全傷口適應症產品註冊申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-04-23 17:45，「公告本公司今日接獲註冊代理人通知，埃及藥物監督管理局(EDA)受理Bonvadis外用乳膏完全傷口適應症產品註冊申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-04-23-1741-1tymdfq","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"17:41:17","subject":"本公司之Tripod-Fix可擴張椎體強化系統取得巴西國家衛生監督局(ANVISA) 上市銷售許可。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-04-23 17:41，「本公司之Tripod-Fix可擴張椎體強化系統取得巴西國家衛生監督局(ANVISA) 上市銷售許可。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-04-23-1735-isqttc","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-04-23","time":"17:35:30","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2025-04-23","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-04-23 17:35，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-04-23-1710-131hgl8","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-04-23","time":"17:10:12","subject":"公告本公司脂肪肝炎新藥SNP-630取得加拿大專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-04-23 17:10，「公告本公司脂肪肝炎新藥SNP-630取得加拿大專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-04-23-1653-mu5859","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"16:53:54","subject":"公告本公司資金貸與超限改善計畫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-04-23 16:53，「公告本公司資金貸與超限改善計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-04-23-1638-1uuc37d","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"16:38:14","subject":"公告本公司董事會決議對子公司意能生技股份有限公司增加投資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-04-23 16:38，「公告本公司董事會決議對子公司意能生技股份有限公司增加投資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-04-23-1615-kxgk3x","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"16:15:01","subject":"公告本公司發言人及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-04-23 16:15，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-04-23-1611-9769qc","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"16:11:46","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-04-23 16:11，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-04-23-1610-1g6i233","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"16:10:50","subject":"公告本公司董事長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-04-23 16:10，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-23-1537-1udlkxg","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-23","time":"15:37:27","subject":"公告本公司收到治療阿茲海默症藥物之中國專利核准通知書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-23 15:37，「公告本公司收到治療阿茲海默症藥物之中國專利核准通知書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-04-23-1529-34098y","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-04-23","time":"15:29:16","subject":"公告本公司董事會通過114年第一季個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-04-23 15:29，「公告本公司董事會通過114年第一季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-04-23-1439-7ammwo","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-04-23","time":"14:39:51","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSAND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES」韓國專利核准通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-04-23 14:39，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSAND CRYSTALLINE F」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-04-23-1013-1fqkmsr","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-04-23","time":"10:13:47","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-04-23 10:13，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}